Validity of Patient-Reported Swallowing and Speech Outcomes in Relation to Objectively Measured Oral Function Among Patients Treated for Oral or Oropharyngeal Cancer

Dysphagia

Volumn 30, Issue 2, 2015, Pages 196-204

  Rinkel, R N P M ^a   Verdonck de Leeuw, I M ^a   de Bree, R ^a   Aaronson, N K ^b   Leemans, C R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Deglutition; Deglutition disorder; Dysphagia; Head and neck cancer; Oral function; Speech; Trismus; Xerostomia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONSTRUCT VALIDITY; CONVERGENT VALIDITY; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; FUNCTIONAL REHABILITATION OUTCOME SCALE; HUMAN; MALE; MOUTH CANCER; OROPHARYNX CANCER; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SHOULDER; SPEECH; SPEECH HANDICAP INDEX; SWALLOWING; SWALLOWING QUALITY OF LIFE QUESTIONNAIRE; VERY ELDERLY; DEGLUTITION DISORDERS; MIDDLE AGED; MOUTH NEOPLASMS; NONPARAMETRIC TEST; OROPHARYNGEAL NEOPLASMS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMETRY; QUALITY OF LIFE; SELF REPORT; TREATMENT OUTCOME; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; DEGLUTITION; DEGLUTITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; SELF REPORT; SPEECH; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84929950801     PISSN: 0179051X     EISSN: 14320460     Source Type: Journal    
DOI: 10.1007/s00455-014-9595-9     Document Type: Article

References (38)

1. Verdonck-de Leeuw IM, van Nieuwenhuizen A, Leemans CR. The value of quality-of-life questionnaires in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2012;20(2):142–7.
2. Dysphagia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO), Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM, Gibson RJ, Eilers JG, Waltimo T, Bots CP, Michelet M, Sollecito TP, Rouleau TS, Sewnaik A, Bensadoun RJ, Fliedner MC, Silverman S Jr, Spijkervet FK. Swallowing dysfunction in cancer patients. Support Care Cancer. 2012;20(3):433–43.
3. Rinkel RN, Verdonck-de Leeuw IM, van Reij EJ, Aaronson NK, Leemans CR. Speech Handicap Index in patients with oral and pharyngeal cancer: better understanding of patients complaints. Head Neck. 2008;30:868–74.
4. Rinkel RN, Verdonck-de Leeuw IM, Langendijk JA, van Reij EJ, Aaronson NK, Leemans CR. The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral Oncol. 2009;45(8):e67–71.
5. McHorney CA, Bricker DE, Robbins J, Kramer AE, Rosenbek JC, Chignell KA. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling. Dysphagia. 2000;15(3):122–33.
6. McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, Bricker DE. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17(2):97–114.
7. McHorney CA, Martin-Harris B, Robbins J, Rosenbek J. Clinical validity of the SWAL-QOL and SWAL-CARE outcome tools with respect to bolus flow measures. Dysphagia. 2006;21(3):141–8 Erratum in: Dysphagia 23(4):461, 2008.
8. Rogus-Pulia NM, Pierce M, Mittal BB, Zecker SG, Logemann J. Bolus effects on patient awareness of swallowing difficulty and swallow physiology following chemoradiation for head and neck cancer. Head Neck. 2014;. doi:10.1002/hed.23720.
9. Kendall KA, Kosek SR, Tanner K. Quality-of-life scores compared to objective measures of swallowing after oropharyngeal chemoradiation. Laryngoscope. 2014;124(3):682–7.
10. Khaldoun E, Woisard V, Verin E. Validation in French of the SWAL-QOL scale in patients with oropharyngeal dysphagia. Gastroenterol Clin Biol. 2009;33(3):167–71.
11. Bogaardt HC, Speyer R, Baijens LW, Fokkens WJ. Cross-cultural adaptation and validation of the Dutch version of SWAL-QOL. Dysphagia. 2009;24(1):66–70.
12. Lam PM, Lai CK. The validation of the Chinese version of the Swallow Quality-of-Life Questionnaire (SWAL-QOL) using exploratory and confirmatory factor analysis. Dysphagia. 2011;26(2):117–24.
13. Dwivedi RC, St Rose S, Roe JW, Chisholm E, Elmiyeh B, Nutting CM, Clarke PM, Kerawala CJ, Rhys-Evans PH, Harrington KJ, Kazi R. First report on the reliability and validity of speech handicap index in native English-speaking patients with head and neck cancer. Head Neck. 2011;33(3):341–8.
14. Dwivedi RC, Rose S, Chisholm EJ, Bisase B, Amen F, Nutting CM, Clarke PM, Kerawala CJ, Rhys-Evans PH, Harrington KJ, Kazi R. Evaluation of speech outcomes using English version of the Speech Handicap Index in a cohort of head and neck cancer patients. Oral Oncol. 2012;48(6):547–53.
15. Finizia C, Rudberg I, Bergqvist H, Rydén A. A cross-sectional validation study of the Swedish version of SWAL-QOL. Dysphagia. 2012;27(3):325–35.
16. Vanderwegen J, Van Nuffelen G, DeBodt M. The validation and psychometric properties of the Dutch version of the Swallowing Quality-of-Life Questionnaire (DSWAL-QOL). Dysphagia. 2013;28(1):11–23.
17. Degroote G, Simon J, Borel S, Crevier-Buchman L. The French version of Speech Handicap Index: validation and comparison with the Voice Handicap Index. Folia Phoniatr Logop. 2012;64(1):20–5.
18. Thompson WRE, Jackson M, Dawson F, Jackson T, Brown A, Robertson AG, MacDonald DG, Camilleri IG, Soutar DS. Figuring function with FIGS and FROG—functional rehabilitation after oral cancer. Oral Oncol Suppl. 2005;1(1):75.
19. Borggreven PA, Verdonck-de Leeuw IM, Muller MJ, Heiligers ML, de Bree R, Aaronson NK, Leemans CR. Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study. Eur Arch Otorhinolaryngol. 2007;264(6):651–7.
20. de Bruijn M, ten Bosch L, Kuik DJ, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM. Artificial neural network analysis to assess hypernasality in patients treated for oral or oropharyngeal cancer. Logoped Phoniatr Vocol. 2011;36(4):168–74.
21. de Bruijn MJ, ten Bosch L, Kuik DJ, Quené H, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM. Objective acoustic-phonetic speech analysis in patients treated for oral or oropharyngeal cancer. Folia Phoniatr Logop. 2009;61(3):180–7.
22. Ding R, Logemann JA. Patient self-perceptions of swallowing difficulties as compared to expert ratings of videofluorographic studies. Folia Phoniatr Logop. 2008;60(3):142–50.
23. Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A, MacCracken E, Gaziano J, Stachowiak L. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck. 2002;24:555–65.
24. Jensen K, Bonde JA, Grau C. The relationship between observer-based toxicity scoring and patient assessed symptoms severity after treatment for head and neck cancer. A correlative crosssectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol. 2006;78:298–305.
25. Rhodus NL, Moller K, Colby S, Bereuter J. Dysphagia in patients with three different etiologies of salivary dysfunction. Ear Nose Throat J. 1995;74:45–8.
26. Teguh DN, Levendag PC, Noever I, van Rooij P, Voet P, van der Est H, Sipkema D, Sewnaik A, Baatenburg de Jong RJ, de la Bije D, Schmitz PI. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 2008;15:1119–27.
27. Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Mittal B, Gaziano J, Stachowiak L, MacCracken EM, Newman LA. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck. 2003;25:432–7.
28. Oskam IM, Verdonck-de Leeuw IM, Aaronson NK, Witte BI, de Bree R, Doornaert P, Langendijk JA, Leemans CR. Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care. Oral Oncol. 2013;49(5):443–8.
29. Duke RL, Campbell BH, Indresano AT, Eaton DJ, Marbella AM, Myers KB, Layde PM. Dental status and quality of life in long-term head and neck cancer survivors. Laryngoscope. 2005;115(4):678–83.
30. Wall LR, Ward EC, Cartmill B, Hill AJ. Physiological changes to the swallowing mechanism following (chemo)radiotherapy for head and neck cancer: a systematic review. Dysphagia. 2013;28(4):481–93.
31. Christianen ME, Schilstra C, Beetz I, Muijs CT, Chouvalova O, Burlage FR, Doornaert P, Koken PW, Leemans CR, Rinkel RN, de Bruijn MJ, de Bock GH, Roodenburg JL, van der Laan BF, Slotman BJ, Verdonck-de Leeuw IM, Bijl HP, Langendijk JA. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2012;105(1):107–14.
32. Popovtzer A, Cao Y, Feng FY, Eisbruch A. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study. Radiother Oncol. 2009;93(3):510–5.
33. van der Molen L, Heemsbergen WD, de Jong R, van Rossum MA, Smeele LE, Rasch CR, Hilgers FJ. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother Oncol. 2013;106(3):364–9.
34. Almeida FR, Furuyama RJ, Chaccur DC, Lowe AA, Chen H, Bittencourt LR, Frigeiro ML, Tsuda H. Complete denture wear during sleep in elderly sleep apnea patients: a preliminary study. Sleep Breath. 2012;16(3):855–63.
35. Arisaka H, Sakuraba S, Tamaki K, Watanabe T, Takeda J, Yoshida K. Effects of wearing complete dentures during sleep on the apnea-hypopnea index. Int J Prosthodont. 2009;22(2):173–7.
36. Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014;120(13):1975–84.
37. Verdonck-de Leeuw IM, Eerenstein SE, Van der Linden MH, Kuik DJ, de Bree R, Leemans CR. Distress in spouses and patients after treatment for head and neck cancer. Laryngoscope. 2007;117(2):238–41.
38. van Nieuwenhuizen AJ, Buffart LM, Smit JH, Brakenhoff RH, Braakhuis BJ, de Bree R, Leemans CR, Verdonck-de Leeuw IM. A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible? Support Care Cancer. 2014;22(12):3321–30.